Skip to content

Clinical trials

Completed Observational End Stage Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Phase: Observational Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20101
20114
20122
20131
20141
20153
20191
20201
20213
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre hospitalier de l'Université de Montréal (CHUM)2
Mayo Clinic2
Virginia Commonwealth University2
Arbor Research Collaborative for Health1
Asan Medical Center1
Chang Gung Memorial Hospital1
Cook Research Incorporated1
Hacettepe University1
Hasan Kalyoncu University1
Henry Ford Health System1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease24
Liver Cirrhosis3
Fibrosis2
Frailty2
Hepatitis C2
Hypertension, Portal2
Liver Diseases2
Acute Kidney Injury1
Acute-On-Chronic Liver Failure1
COVID-191

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.